SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000914121-05-000628
Filing Date
2005-03-21
Accepted
2005-03-21 11:04:14
Documents
1
Group Members
RICHARD C. PERRY

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D AMENDMENT NO. 1 pe707685-13da1.txt SC 13D/A 12386
  Complete submission text file 0000914121-05-000628.txt   13969
Mailing Address 1500 CORPORATE DRIVE SUITE 400 CANONSBURG PA 15317
Business Address 1500 CORPORATE DRIVE SUITE 400 CANONSBURG PA 15317 724-514-1800
MYLAN LABORATORIES INC (Subject) CIK: 0000069499 (see all company filings)

IRS No.: 251211621 | State of Incorp.: PA | Fiscal Year End: 0331
Type: SC 13D/A | Act: 34 | File No.: 005-10728 | Film No.: 05693351
SIC: 2834 Pharmaceutical Preparations

Mailing Address 599 LEXINGTON 36TH FL NEW YORK NY 10022
Business Address 599 LEXINGTON AVE 36TH FL NEW YORK NY 10022 2125834100
PERRY CORP (Filed by) CIK: 0000919085 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: SC 13D/A